Pharma manufacturing continues to grapple with a long-standing challenge: balancing innovation with strict regulatory compliance. While AI-driven technologies have the potential to significantly enhance operator capability and execution consistency, their adoption on the shop floor is often constrained by regulatory and validation requirements.

PharmaCloud is designed to address this gap.

PharmaCloud delivers DeepHow’s AI-powered operational knowledge platform through a validated, audit-ready cloud environment purpose-built for regulated pharma manufacturing. The platform enables manufacturers to deploy AI to capture critical expert knowledge, guide operators through standard operating procedures, and verify task execution, while ensuring the governance, traceability, and controls required to meet good manufacturing practice (GMP) standards.

By integrating operator training, standard work execution, and execution verification into a single compliant platform, PharmaCloud allows pharmaceutical manufacturers to modernize frontline operations, reduce execution risk, and improve operational consistency—without adding compliance complexity.

“Pharma manufacturing should not be forced to choose between innovation and audit readiness,” said Sivakumar Lakshmanan, CEO of DeepHow. “PharmaCloud provides a GMP-compliant foundation for deploying advanced AI directly at the point of work, ensuring operators are trained, guided, and verified while performing mission-critical tasks.”

With PharmaCloud, DeepHow introduces a new operating model for regulated pharma manufacturing—one where AI-driven innovation and regulatory compliance are built to work in parallel.